All In Biotech

Drug Trial Radar · NCT03385304

Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures

Aqueous-PREP: A Pragmatic Randomized Trial Evaluating Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures

Last checked: Nov 20, 2026Latest source record: Mar 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,638 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,638

Actual

Start

Apr 8, 2018

Primary completion

Oct 19, 2021

Study completion Jun 27, 2022

Sponsor

Lead sponsor
University of Maryland, BaltimoreAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
McMaster University; United States Department of Defense
First posted
Dec 28, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The prevention of infection is the single most important goal influencing peri-operative care of patients with open fractures. Standard practice in the management of open fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for open fracture surgery.

Conditions

  • Surgical Site Infection
  • Unplanned Fracture-Related Reoperation
  • Open Appendicular Fracture

Interventions

  • 10% povidone-iodine (1% free iodine) in purified waterDrug

    Participant recruitment will begin with the clinical sites using their assigned pre-operative antiseptic skin solution for all open fracture surgeries for a two-month period.

  • 4% chlorhexidine gluconate (CHG) in purified waterDrug

    Once the first intervention phase is completed, each site will crossover to the opposite study solution. Each site will need to develop local procedures to ensure a successful crossover. They will use the second solution for all open fracture surgeries for a two-month period, and will then crossover back to the solution in the first intervention phase.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With a Superficial Incisional Surgical Site Infection (SSI)Time frame: Within 30 days of the patient's last planned fracture management surgery
  2. Number of Participants With a Deep Incisional or Organ/Space InfectionTime frame: Within 90 days of the patient's last planned fracture management surgery

Locations

15 sites in 3 countries. Site status is shown where the registry gives one.

  • The CORE Institute / Banner University Medical Center

    Phoenix, Arizona

  • Banner - University Medical Center Tucson

    Tucson, Arizona

  • University of California San Francisco

    San Francisco, California

  • University of Florida

    Gainesville, Florida

  • Indiana University Health Methodist Hospital

    Indianapolis, Indiana

  • University of Maryland, R Adams Cowley Shock Trauma Center

    Baltimore, Maryland

  • Wright State University / Miami Valley Hospital

    Dayton, Ohio

  • Greenville Health System

    Greenville, South Carolina

  • Vanderbilt University

    Nashville, Tennessee

  • San Antonio Military Medical Center

    Fort Sam Houston, Texas

  • McGovern Medical School at University of Texas Health Science Center Houston

    Houston, Texas

  • Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • McMaster University, Center for Evidence-Based Orthopaedics

    Hamilton, Ontario, Canada

  • Hospital Parc Tauli de Sabadell

    Barcelona, Spain

  • Vall d'Hebron University Hospital

    Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.